EUVIMEDEUVIMED entdecken
Crossref

Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database

Hong Zhou iD, Tingting Chen, Ting Wei, Jinhua Zhang iD

Acta Clinica Belgica · 04.07.2026 · 81 (4) · 303-315

DOI: 10.1080/17843286.2026.2655844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Clinica Belgica, online erschienen am 19.04.2026. Verfasst von Hong Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Me…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Product Surveillance, Postmarketing, Hemorrhage, Antineoplastic Agents. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province of China, Joint Funds for the Innovation of Science and Technology, Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedProduct Surveillance, PostmarketingHemorrhageAntineoplastic AgentsAntibodies, MonoclonalHumansRamucirumabAdverse Drug Reaction Reporting SystemsRetrospective StudiesDatabases, FactualUnited StatesFemaleUnited States Food and Drug AdministrationMale

Stichwörter der Autor:innen

Disproportionality analysisFAERSadverse eventramucirumab

Substanzen

RamucirumabAntibodies, Monoclonal, HumanizedAntineoplastic AgentsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.

ORCID-Profile: Hong Zhou, Jinhua Zhang

Förderung

  • Natural Science Foundation of Fujian Province of China
  • Joint Funds for the Innovation of Science and Technology, Fujian Province

Zitieren

APA

Zhou, H., Chen, T., Wei, T., & Zhang, J. (2026). Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database. Acta Clinica Belgica, 81(4), 303-315. https://doi.org/10.1080/17843286.2026.2655844

Vancouver

Zhou H, Chen T, Wei T, Zhang J. Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database. Acta Clinica Belgica. 2026;81(4):303-315. doi:10.1080/17843286.2026.2655844

BibTeX
@article{Zhou2026,
  author = {Zhou, Hong and Chen, Tingting and Wei, Ting and Zhang, Jinhua},
  title = {Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database},
  journal = {Acta Clinica Belgica},
  year = {2026},
  volume = {81},
  number = {4},
  pages = {303--315},
  doi = {10.1080/17843286.2026.2655844}
}
Kostenlos starten →